The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement
Recruiting
N/A
Interventional Study
Opioid Use
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 96 (estimated)
- Sponsor
- Ajou University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (19-60 years old) with ASA physical status 1, 2, 3
* Scheduled surgery under general anesthesia
Exclusion Criteria:
* The patient does not conset
* Pregnancy
* hepatic disorder
* Renal disorder
* Asthma
* Hypersensitivity to the NSAIDs or acetaminophen
* Patie…
Contacts